The Carcinogenicity of Two Diazadibenzopyrenes by Zajdela, F. et al.
Br. J. Cancer (1972) 26, 262
THE CARCINOGENICITY OF TWO DIAZADIBENZOPYRENES
F. ZAJDELA*, N. P. BUU-HOItt, P. ,JACQUIGNONt AND M. DUFOURt
From * the Unite de Physiologie Cellulaire, INSERM, Institut du Radium, 91-Orsay, and
t Institut de Chimie des Substances Naturelles du CNRS, 91-Gif-sur- Yvette, France
Receivecl for publication December 1971
Summary.-1,12-Diazadibenzo(a,i)pyrene (I), an isostere of the extremely potent
carcinogen dibenzo(a,i)pyrene, also displays carcinogenicity although to a consider-
ably lesser degree than the latter compound. While dibenzo(a,h)pyrene is known to
be distinctly less active than dibenzo(a,i)pyrene, surprisingly 4,11-diazadibenzo(a,h)
pyrene (II) shows a greateractivitythan I. Anotherhexacyclic diaza-hydrocarbon,
4,12-diazadibenzo(g,p)chrysene (III), which is devoid of a meso-phenanthrenic
region, proved totally inactive.
Dibenzo(a,i)pyrene (IV) is the most
potent carcinogenic hydrocarbon known
so far (Lacassagne et al., 1957) in respect
of the speed of its action and the high
incidence of tumours (Lacassagne, Buu-
Hoi and Zajdela, 1958; Waravdekar and
Ranadive, 1958); the isomeric hydro-
carbon dibenzo(a,h)pyrene (V) is also
a highly active carcinogen although
to a lesser degree (Bachmann et al.,
1937; Shabad, 1938; Badger et al., 1940;
Lacassagne et al., 1958). It was interesting
to examine whether, and in which direc-
tion, the oncogenicity of these 2 aromatic
hydrocarbons would be modified by
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replacement of the 2 external benzene
rings by equivalent pyridine ones. Two
compounds which meet this structural
requirement are 1,12-diazadibenzo(a,i)-
pyrene (I), which is isosteric with the
hydrocarbon IV, and 4,11-diazadibenzo-
(a,h)pyrene (II), which is isosteric with
the hydrocarbon V. In these diaza-
hydrocarbons (Dufour, Buu-Hoi and Jac-
quignon, 1967), the two ,neso-phenan-
threnic regions considered important for
the carcinogenicity of these 2 hexacyclic
hydrocarbons (Chalvet and Chalvet, 1955;
Pullman and Pullman, 1955) are intact;
6,7-diazadibenzo(a,i)pyrene (VI), in the
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molecule of which, aza-substitution in-
volves one of these K-zones, is totally
inactive (Homburger, Treger and Boger,
1968).
Compounds I and II were tested for
carcinogenic activity in mice; a third
diaza - hydrocarbon, 4,12 - diazadibenzo -
(q,p)chrysene (III), isomeric with I and II
but possessing no free meso-phenan-
threnic region, was included in this study
for the sake of comparison.
MATERIALS AND METHODS
The substances tested were synthesized
in our laboratory at Gif-sur-Yvette; their
purity (100%) and structure were controlled
by physicochemical methods (microanalyses,
NMR, etc.).
Two strains of mice, Swiss (Carshalton)
and Radium Institute XVII nc/ZE (& and 9),
aged 3 to 4 months, were used. As in all
our carcinogenicity testing experiments, they
were given 3 injections, in the subcutaneous
tissue of the right flank, of 0-6 mg of the
substance under test, dissolved in 0-2 ml
sterile, neutral olive oil, one month elapsing
between each injection. The controls (120
Swiss mice and 680 XVII nc/ZE mice)
received the solvent only. The animals
which did not develop tumours were kept
for over 600 days after the start of the
experiments; those which developed a sar-
coma insitu were sacrificed whenthediameter
ofthe tumourhadreached about 15 mm. For
histopathological examination, the tumours
were fixed in Bouin's solution and embedded
in paraffin, and the sections stained by the
trichrome method (haemalum/eosin/saffron).
Post-mortem examinations were performed
on all the animals and a search made for
possible remote tumours.
Compound I was tested in 28 mice and
compound II in 27; compound III was
tested in 30 mice.
RESULTS AND DISCUSSION
The tests for carcinogenicity gave very
similar results in the 2 strains of mice.
As dibenzo(a,i)pyrene (IV), inoculated
TABLE.-Sarcomagenic Activity of Compounds I and II
Strain XVII nc/ZE
(Radium Institute)
t AA
, A-&A , C
Latency Latency Latency
Day period of Day period of Day period of
killed sarcomata killed sarcomata killed sarcomata
1,12-Diazadibenzo(a,i)pyrene (Compound I)
146 122 185 142 . 131 100
230 192 185 142 . 190 152
251 207 632 . 195 160
462 - 632 . 210 192
632 632 . 632
632 632 . 632
632 - 632 - . 632
181
181
181
181
204
284
364
Latency
Day period of
killed sarcomata
162
172
632
632
632
632
632
Mean latency time, 154 days. Iball index,* 25. Yield of tumours, 39%.
4,1 1-Diazadibenzo(a,h)pyrene (Compound II)
142 154 108 . 162 137 162
142 181 139 . 173 137 162
162 181 145 182 145 205
162 181 162 . 182 145 205
162 204 162 . 205 180 232
242 210 175 262 230 632
350 632 262 230 -
Mean latency time, 175 days. Iball index,* 53. Yield of tumours, 93%.
138
150
124
124
182
182
203
* Iball index (sarcoma index) is obtained by dividing the percentage of tumours of animals alive at the
appearance of the first tumour by the mean latency period in days and multiplying by 100 (Iball, 1939).
Strain Swiss
(Carshalton)
A
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previously under identical conditions in
male mice (Lacassagne et al., 1958),
gives 100% of tumours with a mean
latency time as short as 75 days (Iball
index, 128), it can be seen from the
Table that its diaza counterpart (I) is
considerably less active both in respect
of yields of tumours (39%O) and of the
mean latency period (154 days), giving
an Iball index of only 25.
On the other hand, the diaza counter-
part (II) of dibenzo(a,h)pyrene (V) gave
nearly the same yield of tumours (93%)
as its hydrocarbon analogue tested in
earlier experiments (Lacassagne et al.,
1958) with, however, a longer latency
time (175 days compared with 111 days),
which gives the diaza product II an
Iball index of 53 compared with 78 for
the original hydrocarbon. These results
indicate that the introduction of 2 nitro-
gen atoms in the skeleton of carcinogenic
dibenzopyrenes does not suppress their
sarcomagenic potency ifthe two K-regions
remain intact. The superiority of II
over I in producing tumours is unexpected
considering that the situation is the
reverse in the case of their hydrocarbon
models V and IV.
These 2 examples emphasize the diffi-
culty of making any prediction of the
degree of carcinogenicity of nitrogen
analogues of hydrocarbons, and point to
the likelihood of encountering large num-
bers of carcinogens among them.
Compound III was completelyinactive,
all the animals having survived over 675
days without showing any tumour at
sacrifice, except for 2 mice, one a Swiss Y,
which died after 472dayswith ahepatoma,
probably spontaneous, the other, a XVII
nc/ZE, $, which died without tumour on
the 562nd day.
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